Dr. Hossein Borghaei earned his medical degree from Philadelphia College of Osteopathic Medicine. He completed his internal medicine residency at the Graduate Hospital in Philadelphia and his hematology/oncology fellowship at the Fox Chase Cancer Center in Philadelphia, where he currently practices as a medical oncologist.
Dr. Borghaei’s special areas of interest include lung cancer, targeted therapy, monoclonal antibody therapy, immunotherapy, and cancer vaccines. With regard to lung cancer, he is especially passionate about prevention and early detection of the disease.
Dr. Hossein Borghaei works to improve his patients’ immune response to cancer.
Dr. Borghaei’s laboratory works to develop new cancer treatments within the field of immunotherapy. These therapies include monoclonal antibody drugs, among drugs, and cancer vaccines to improve his patients’ immune response to cancer.
Dr. Borghaei recognizes that relapses with cancer are common, especially with asbestos-related cancers like mesothelioma and lung cancer. When these cancers are said to have gone into remission, it does not mean that the cancer is gone for good. Sometimes it returns, complicating treatment.
The biggest problem is how after a while, cancerous cells can adapt and become resistant to some of the chemotherapeutic drugs, another reason why Dr. Borghaei works to connect his patients with novel treatments like immunotherapy to help provide them with the best care.